Upgrade to SI Premium - Free Trial

Alkermes (ALKS) PT Lowered to $45 at Cowen Following 4Q

February 15, 2019 8:30 AM
Cowen analyst Chris Shibutani lowered the price target on Alkermes (NASDAQ: ALKS) to $45.00 (from $53.00) while maintaining a Outperform ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles